Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization

Publisher： Karger

E-ISSN： 1423-0232|87|6|330-341

ISSN： 0030-2414

Source： Oncology, Vol.87, Iss.6, 2014-09, pp. : 330-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgical resection versus transarterial chemoembolization for BCLC stage C hepatocellular carcinoma

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 4, 2015-04 ,pp. : 404-409

John Wiley & Sons Inc

Access to resources Recommend Favorite

Percutaneous Radiofrequency Ablation for Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 19-26

Karger

Access to resources Recommend Favorite

Evaluation of ART Scores for Repeated Transarterial Chemoembolization in Japanese Patients with Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 4-10

Karger

Access to resources Recommend Favorite

Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma

By  

Oncology, Vol. 89, Iss. 2, 2015-0 ,pp. : 47-52

Karger

Access to resources Recommend Favorite

In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 2, 2015-02 ,pp. : 627-635

John Wiley & Sons Inc

Access to resources Recommend Favorite